What are the latest College of Physicians and Surgeons of Ontario (CPSO) reporting requirements for severe Obstructive Sleep Apnea (OSA) and driving?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 27, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Research

The College of Physicians and Surgeons of Ontario (CPSO) requires physicians to report patients with severe obstructive sleep apnea (OSA) who continue to drive despite medical advice to refrain, specifically those with an Apnea-Hypopnea Index (AHI) greater than 30 events per hour, excessive daytime sleepiness, and a history of motor vehicle collision or near-miss due to sleepiness, fatigue, or inattention. The reporting requirement applies when patients refuse to comply with treatment recommendations and continue driving against medical advice, as highlighted in various studies 1, 2, 3, 4, 5. Key points to consider in managing OSA and driving include:

  • Assessing the severity of OSA and its impact on driving safety
  • Discussing driving risks and treatment recommendations with patients
  • Attempting to address the patient's condition through appropriate treatment options, such as CPAP therapy, which is typically considered effective when used for at least 4 hours per night for 70% of nights
  • Documenting discussions with patients about driving risks, treatment recommendations, and any reporting actions taken
  • Balancing patient confidentiality with public safety concerns, as untreated severe OSA significantly increases collision risk due to impaired alertness, reaction time, and cognitive function caused by chronic sleep fragmentation and intermittent hypoxemia, as noted in a study published in the Journal Postgraduate medicine 2. It is essential to prioritize the most recent and highest quality study, which in this case is the 2021 study published in Postgraduate medicine 2, to guide clinical decision-making and ensure the best possible outcomes for patients with severe OSA.

Related Questions

As a 30-year-old non‑overweight male without snoring but with persistent fatigue and a past episode of waking gasping for air, should I be concerned about obstructive sleep apnea and possible organ damage, and is an at‑home sleep test appropriate?
Which condition increases the risk of obstructive sleep apnea (OSA) in this patient, coronary artery disease (CAD), generalized anxiety disorder (GAD), hypothyroidism, nonalcoholic fatty liver disease (NAFLD), or osteoporosis?
Are Attention Deficit Hyperactivity Disorder (ADHD) stimulants safe to use in patients with Obstructive Sleep Apnea (OSA)?
Can continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA) improve lumbar (lower back) pain?
In a 52-year-old obese female with loud snoring, daytime fatigue, hypertension, neck circumference 42 cm, and a home sleep apnea test showing an apnea‑hypopnea index of 3.8 events per hour with nadir oxygen saturation of 89%, what is the next recommended management step?
Is Fioricet (butalbital, acetaminophen, and caffeine) safe for adolescents?
What is the difference between Ivabradine (Corlanor) and Eplerenone (Inspra) in treating heart conditions?
What intervention improves survival in a 69-year-old female with a history of chronic hypertension, previous myocardial infarction (MI), left ventricular ejection fraction (LVEF) of 32%, and symptoms of heart failure, currently treated with aspirin (acetylsalicylic acid), atorvastatin, Lasix (furosemide), Lisinopril (Lisipril), and Toprol XL (metoprolol succinate)?
What are the symptoms of an allergic reaction to Gabapentin (Neurontin)?
What are the best ways to lower Hemoglobin A1c (HbA1c) at a level of 5.8?
What is the pathophysiology of lidocaine (local anesthetic) toxicity-induced hypoxemia (low blood oxygen levels)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.